Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ASPI Stock Forecast 2026-2027
$3.95
Current Price
$576.64M
Market Cap
Buy 3
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to ASPI Price Targets
+280.2%
To High Target of $15.00
+229.5%
To Median Target of $13.00
+178.8%
To Low Target of $11.00
ASPI Price Momentum
-21.4%
1 Week Change
-41.0%
1 Month Change
-59.2%
1 Year Change
-26.4%
Year-to-Date Change
-72.8%
From 52W High of $14.49
+2.1%
From 52W Low of $3.87
📊 TOP ANALYST CALLS
Did ASPI Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Aspire Real Estate is one of their latest high-conviction picks.
Latest ASPI Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, ASPI has a bullish consensus with a median price target of $13.00 (ranging from $11.00 to $15.00). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $3.95, the median forecast implies a 229.5% upside. This outlook is supported by 3 Buy, 0 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by George Gianarikas at Canaccord Genuity, suggesting a 178.8% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ASPI Analyst Ratings
3
Buy
0
Hold
0
Sell
ASPI Price Target Range
Low
$11.00
Average
$13.00
High
$15.00
Current: $3.95
Latest ASPI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ASPI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 14, 2026 | Canaccord Genuity | George Gianarikas | Buy | Maintains | $11.00 |
| Dec 4, 2025 | Cantor Fitzgerald | Overweight | Initiates | $N/A | |
| Nov 24, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Sep 17, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| May 21, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Oct 18, 2024 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Oct 4, 2024 | Canaccord Genuity | Buy | Initiates | $N/A | |
| Aug 7, 2024 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Apr 17, 2024 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Feb 29, 2024 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Dec 5, 2023 | HC Wainwright & Co. | Buy | Initiates | $N/A |
ASP Isotopes Inc. (ASPI) Competitors
The following stocks are similar to Aspire Real Estate based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
ASP Isotopes Inc. (ASPI) Financial Data
ASP Isotopes Inc. has a market capitalization of $576.64M with a P/E ratio of -2.2x. The company generates $26.93M in trailing twelve-month revenue with a 14.3% profit margin.
Revenue growth is +279.3% quarter-over-quarter, while maintaining an operating margin of -595.4% and return on equity of -103.3%.
Valuation Metrics
Market Cap
$576.64M
Enterprise Value
$559.23M
P/E Ratio
-2.2x
PEG Ratio
0.0x
Price/Sales
22.0x
Growth & Margins
Revenue Growth (YoY)
+279.3%
Gross Margin
+39.9%
Operating Margin
-595.4%
Net Margin
+14.3%
EPS Growth
+279.4%
Financial Health
Cash/Price Ratio
+58.5%
Current Ratio
4.4x
Debt/Equity
87.6x
ROE
-103.3%
ROA
-13.7%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
ASP Isotopes Inc. (ASPI) Business Model
About ASP Isotopes Inc.
What They Do
Produces high-value isotopes for various applications.
Business Model
The company operates by enriching and producing scarce isotopes that cater to industries such as nuclear medicine, semiconductors, and green energy. It generates revenue through the sale of these enriched isotopes and related services, leveraging its proprietary technology to meet the high-purity material demands of its customers.
Additional Information
Incorporated in 2021 and headquartered in Washington, D.C., ASP Isotopes Inc. has its manufacturing and enrichment activities based in South Africa, targeting a global customer base in specialized and regulated markets.
Company Information
Sector
Basic Materials
Industry
Chemicals
Employees
271
CEO
Mr. Paul Elliot Mann C.F.A.
Country
United States
IPO Year
2022
Website
aspisotopes.comASP Isotopes Inc. (ASPI) Latest News & Analysis
Latest News
ASP Isotopes Announces Agreements to Exchange Certain QLE Convertible Notes for ASPI Common Stock
2 days ago
Quick Summary
Exchange has reduced QLE's outstanding convertible notes by about 50% as QLE aims for a public listing as an independent company.
Why It Matters
Reducing QLE's convertible notes improves its balance sheet, potentially enhancing its appeal to investors ahead of a public listing, which could lead to increased capital and growth opportunities.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
ASP Isotopes Inc. (NASDAQ: ASPI) and ENDRA Life Sciences Inc. (NASDAQ: NDRA) announced a collaboration focused on the production of critical materials and advanced imaging technologies for liver disease detection.
Why It Matters
The partnership between ASP Isotopes and ENDRA may enhance both companies' market positions, potentially leading to increased revenue streams and growth in critical materials and medical imaging sectors.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
ASP Isotopes has signed three contracts to supply enriched Silicon-28 to U.S. customers, with initial shipments expected in Q3 2026. Their enrichment facility is operating successfully.
Why It Matters
ASP Isotopes' contracts for enriched Silicon-28 and operational success of its facility signal potential revenue growth and market confidence, impacting stock performance and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
ASP Isotopes Inc. (NASDAQ:ASPI) shares rose after the company announced the restart of its Silicon-28 enrichment facilities in Pretoria, South Africa.
Why It Matters
The restart of Silicon-28 enrichment facilities signals potential revenue growth and operational progress for ASP Isotopes, positively impacting investor sentiment and stock performance.
Source: Benzinga
Market Sentiment:
Positive
Quick Summary
ASP Isotopes Inc. (NASDAQ:ASPI) shares rose after its subsidiary, Quantum Leap Energy LLC, signed a non-binding MOU with a European nuclear firm for advanced nuclear fuel collaboration.
Why It Matters
The partnership with a European nuclear technology firm could enhance ASP Isotopes' market position and revenue potential in the growing nuclear energy sector, boosting investor confidence.
Source: Benzinga
Market Sentiment:
Positive
Quick Summary
An MOU has been established to collaborate on supplying HALEU to a European advanced reactor developer, starting in 2028.
Why It Matters
The MOU indicates future revenue potential and strategic partnerships in the growing advanced nuclear sector, enhancing market confidence and investment opportunities.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About ASPI Stock
What is ASP Isotopes Inc.'s (ASPI) stock forecast for 2027?
Based on our analysis of 2 Wall Street analysts, ASP Isotopes Inc. (ASPI) has a median price target of $13.00. The highest price target is $15.00 and the lowest is $11.00.
Is ASPI stock a good investment in 2027?
According to current analyst ratings, ASPI has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $3.95. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ASPI stock?
Wall Street analysts predict ASPI stock could reach $13.00 in the next 12 months. This represents a 229.5% increase from the current price of $3.95. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is ASP Isotopes Inc.'s business model?
The company operates by enriching and producing scarce isotopes that cater to industries such as nuclear medicine, semiconductors, and green energy. It generates revenue through the sale of these enriched isotopes and related services, leveraging its proprietary technology to meet the high-purity material demands of its customers.
What is the highest forecasted price for ASPI ASP Isotopes Inc.?
The highest price target for ASPI is $15.00 from at , which represents a 280.2% increase from the current price of $3.95.
What is the lowest forecasted price for ASPI ASP Isotopes Inc.?
The lowest price target for ASPI is $11.00 from George Gianarikas at Canaccord Genuity, which represents a 178.8% increase from the current price of $3.95.
What is the overall ASPI consensus from analysts for ASP Isotopes Inc.?
The overall analyst consensus for ASPI is bullish. Out of 2 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $13.00.
How accurate are ASPI stock price projections?
Stock price projections, including those for ASP Isotopes Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 17, 2026 2:07 AM UTC